BlackRock
INBS icon

BlackRock’s Intelligent Bio Solutions INBS Stock Holding History

BlackRock’s Portfolio INBS Stock Details INBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-13
Closed -$24K – 5911
2022
Q1 		$24K Buy
13
+4
+44% +$9.2K ﹤0.01% 5538
2021
Q4 		$32K Hold
9
– – ﹤0.01% 5479
2021
Q3 		$55K Buy
+9
New +$69K ﹤0.01% 5272
2021
Q2 		– Sell
-1
Closed -$9.57K – 5427
2021
Q1 		$8K Buy
+1
New +$17.2K ﹤0.01% 5104

Other funds holding INBS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock's INBS Position: Q2 2022 in Review

BlackRock sold out of Intelligent Bio Solutions (INBS) in Q2 2022, closing a stake of 13 shares — an estimated $24K sold.

BlackRock first reported a position in INBS in Q1 2021 and held it in 4 quarters. The position peaked at $55K in Q3 2021. 12 funds tracked by Wall St. Rank hold INBS as of Q2 2022.

  • BlackRock reported no remaining Intelligent Bio Solutions position as of Q2 2022 after selling out during the quarter.
  • BlackRock sold 13 Intelligent Bio Solutions shares in Q2 2022, an estimated $24K.
  • BlackRock first reported a position in Intelligent Bio Solutions in Q1 2021 and held it in 4 quarters.
  • BlackRock's Intelligent Bio Solutions position peaked at $55K in Q3 2021.
  • 12 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q2 2022.

Based on BlackRock's 13F filing for Q2 2022, filed 12 Aug 2022.